Sanda to lead multi-center prostate cancer biomarker study

Sanda to lead multi-center prostate cancer biomarker study

The combined group of esteemed researchers will work to confirm the ability of novel, Emory-developed detection tools to predict aggressive prostate cancer early on, thereby enhancing survival benefits of treatment and reducing the harm of over

(Visited 2 times, 1 visits today)
5
Like
Save

Comments

Write a comment